SCHEMBL4881025

SCHEMBL4881025

O=C(O)NC[C@H]1CN(c2ccc(C3[C@H]4COC[C@@H]34)cc2)C(=O)O1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 19/20 0.50
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
ITGB3 P05106 2/20 0.46
PRSS1 P07477 2/20 0.46
PRSS2 P07478 2/20 0.46
ITGA2B P08514 2/20 0.46
PRSS3 P35030 2/20 0.46
F2 P00734 2/20 0.46
ABCB11 O95342 1/20 0.46
ST14 Q9Y5Y6 1/20 0.46
LMNA P02545 1/20 0.46
MAOA P21397 1/20 0.46
PTGS1 P23219 1/20 0.46
MAOB P27338 1/20 0.46
CALML3 P27482 1/20 0.46
SDHA P31040 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14197139 0.89 MAOA (0.58) F10CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4874544 0.89 MAOA (0.58) F10CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL14197146 0.84 MAOB (0.46) F10CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9823175 0.83 F10 (0.62) F10F2ABCB11
SCHEMBL9815523 0.83 F10 (0.54) F10CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5764261 0.83 F10 (0.54) F10CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9815493 0.80 F10 (0.49) F10CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7020236 0.80 MAOA (0.57) F10ITGB3PRSS1PRSS2ITGA2B
SCHEMBL9815558 0.80 F10 (0.51) F10CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL14838774 0.79 F10 (0.73) F10CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES PFIZER INC 2008-04-17 US disclosed
US-7279494-B2 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues PFIZER INC. (US) 2007-10-09 US disclosed
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues RENSLO ADAM (US) 2005-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues OXA1L, CYP51A1, CYP2C19 F10 3090/4885CYP1A2 110/4885CYP3A4 36/4885
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES OXA1L, CYP51A1, CYP2C19 F10 3129/4885CYP1A2 115/4885CYP3A4 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.